Company: BLRX
Filing Date: 2025-01-07
Form Type: 424B5
Source: 0001178913-25-000045
Chunk: 40

Company: BioLineRx Ltd.
Filing Date: 2025-01-07
Form: 424B5
Chunk 40
---
 action was brought in the foreign court, a lawsuit in the same matter and between the same parties was pending before a court or tribunal in Israel. |

If a foreign judgment is enforced by an Israeli court, it generally will be payable in Israeli currency, which can then be converted into non-Israeli currency and transferred out of Israel. The usual practice in an action before an Israeli court to recover an amount in a non-Israeli currency is for the Israeli court to issue a judgment for the equivalent amount in Israeli currency at the rate of exchange in force on the date of the judgment, but the judgment debtor may also make payment in foreign currency. Pending collection, the amount of the judgment of an Israeli court stated in Israeli currency ordinarily will be linked to the Israeli consumer price index plus interest at the annual statutory rate set by Israeli regulations prevailing at the time. Judgment creditors must bear the risk of unfavorable exchange rates. S - 22 BioLineRx USA, Inc. is the U.S. agent authorized to receive service of process in any action against us arising out of this offering. The address of BioLineRx USA, Inc. is 77 Fourth Ave., Waltham, MA 02451. EXPENSES The following table sets forth costs and expenses, other than any placement agent fees and expenses, we expect to incur in connection with the offering.

| Depositary fees and expenses |     | $ | 180,000 |
| Legal fees and expenses      |     | $ |  50,000 |
| Accounting fees and expenses |     |   |   3,000 |
| Total                        |     | $ | 233,000 |

S - 23

PROSPECTUS BioLineRx Ltd. $250,000,000 Ordinary Shares American Depositary Shares Representing Ordinary Shares Debt Securities Subscription Rights Warrants
Units We may offer, issue, and sell from time to time up to $250,000,000 of our ordinary shares, including in the form of American Depositary Shares, or ADSs, warrants to purchase ordinary shares, including in the form of ADSs, debt securities, subscription rights and a combination of such securities, separately or as units, in one or more offerings. Each ADS represents 15 ordinary shares. This prospectus provides a general description of offerings of these securities that we may undertake. We refer to the ADSs, ordinary shares, debt securities, subscription rights, warrants and units, collectively, as the “securities” in this prospectus. We may offer, issue, and